ARTICLE | Clinical News
Ziagen abacavir regulatory update
March 9, 2009 7:00 AM UTC
FDA cautioned healthcare professionals against using skin patch testing to immunologically confirm suspected cases of hypersensitivity reactions in patients treated with abacavir. The agency said data...